AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19079276 — intervention group
Group type: EXPERIMENTAL
Intervention: Playing video and computer games
Number of subjects: 538
Study 19079276 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity (moderate, 3.5 METs)
Number of subjects: 538
Study 19079276 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading/doing homework
Number of subjects: 538
Study 16887369 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular Aneurysm Repair (EVAR)
Number of subjects: 32
Study 16887369 — intervention group
Group type: COMPARATOR
Intervention: Open Aneurysm Repair (OAR)
Number of subjects: 32
Study 12594104 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD)
Number of subjects: 51
Study 12594104 — intervention group
Group type: COMPARATOR
Intervention: Control diet (CD)
Number of subjects: 51
Study 11000669 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% sevoflurane
Number of subjects: 120
Study 11000669 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% sevoflurane
Number of subjects: 120
Study 11000669 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% sevoflurane
Number of subjects: 120
Study 11000669 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% sevoflurane
Number of subjects: 120
Study 8633511 — intervention group
Group type: EXPERIMENTAL
Intervention: L-365,260 administered every 6 hours over a 5-7 day period
Number of subjects: 0
Study 8633511 — intervention group
Group type: EXPERIMENTAL
Intervention: L-365,260
Number of subjects: 0
Study 1604908 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride (NaF) tablets for 7 days
Number of subjects: 20
Study 1604908 — intervention group
Group type: COMPARATOR
Intervention: Sodium monofluorophosphate (MFP) tablets for 7 days
Number of subjects: 20
Study 3533891 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 290
Study 3533891 — intervention group
Group type: COMPARATOR
Intervention: Cefamandole
Number of subjects: 290
Study 29379282 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary Rehabilitation (PR) - 12-week program, 3 sessions per week, 60 minutes per session
Number of subjects: 74
Study 29379282 — intervention group
Group type: COMPARATOR
Intervention: Control group - waiting list for admission to PR program
Number of subjects: 74
Study 26548425 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthocyanins (AC)‐rich extract from red oranges, 200 mg administered in two doses (12 and 4 hours before diving)
Number of subjects: 16
Study 26548425 — intervention group
Group type: COMPARATOR
Intervention: Control group (no anthocyanins supplementation)
Number of subjects: 16
Study 23857943 — intervention group
Group type: EXPERIMENTAL
Intervention: Williams LifeSkills training (WLST) for 8 weeks
Number of subjects: 60
Study 23857943 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 60
Study 22402919 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial stapled hemorrhoidopexy (PSH)
Number of subjects: 72
Study 22402919 — intervention group
Group type: COMPARATOR
Intervention: Circular stapled hemorrhoidopexy (CSH)
Number of subjects: 72
Study 20189810 — intervention group
Group type: EXPERIMENTAL
Intervention: VR group (n=9)
Number of subjects: 12
Study 20189810 — intervention group
Group type: COMPARATOR
Intervention: NVR group (n=9)
Number of subjects: 12
Study 18678163 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple acupuncture
Number of subjects: 172
Study 18678163 — intervention group
Group type: EXPERIMENTAL
Intervention: Slowly twirling needle
Number of subjects: 172
Study 18678163 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapidly twirling needle
Number of subjects: 172
Study 18678163 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple lifting-thrusting
Number of subjects: 172
Study 18678163 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifting-thrusting-twirling needle
Number of subjects: 172
Study 15929034 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methotrexate alone
Number of subjects: 37
Study 15929034 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methotrexate with deferred radiotherapy
Number of subjects: 37
Study 15929034 — intervention group
Group type: COMPARATOR
Intervention: High-dose methotrexate without whole-brain radiotherapy
Number of subjects: 37
Study 15929034 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methotrexate
Number of subjects: 37
Study 12828493 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorouracil plus levamisole and folinic acid (B)
Number of subjects: 0
Study 12828493 — intervention group
Group type: COMPARATOR
Intervention: Fluorouracil plus levamisole (A)
Number of subjects: 0
Study 12828493 — intervention group
Group type: EXPERIMENTAL
Intervention: Markov model results (B versus A)
Number of subjects: 0
Study 9988142 — intervention group
Group type: EXPERIMENTAL
Intervention: RenaGel
Number of subjects: 71
Study 9988142 — intervention group
Group type: EXPERIMENTAL
Intervention: RenaGel with calcium (900 mg elemental, once-nightly on an empty stomach)
Number of subjects: 71
Study 9988142 — intervention group
Group type: COMPARATOR
Intervention: Control (washout periods)
Number of subjects: 71
Study 7786885 — intervention group
Group type: EXPERIMENTAL
Intervention: Apomorphine HCl (0.5 mg sc)
Number of subjects: 1
Study 7786885 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study 7786885 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood sampling during apomorphine administration
Number of subjects: 1
Study 2151747 — intervention group
Group type: COMPARATOR
Intervention: 20 mg BY 1023/SK&F 96022
Number of subjects: 12
Study 2151747 — intervention group
Group type: COMPARATOR
Intervention: 40 mg BY 1023/SK&F 96022
Number of subjects: 12
Study 2151747 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 713424 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5 microgram/kg carbachol
Number of subjects: 25
Study 713424 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 microgram/kg pentagastrin
Number of subjects: 25
Study 713424 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 25
Study 30862692 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating tumor DNA (ctDNA) detection before NAT
Number of subjects: 455
Study 30862692 — intervention group
Group type: EXPERIMENTAL
Intervention: Undetectable ctDNA at baseline
Number of subjects: 455
Study 30862692 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent ctDNA detection at baseline and week 2
Number of subjects: 455
Study 30862692 — intervention group
Group type: EXPERIMENTAL
Intervention: Event-free survival (EFS) analysis
Number of subjects: 455
Study 26776270 — intervention group
Group type: EXPERIMENTAL
Intervention: Local RUTF (alternative formulations using local ingredients)
Number of subjects: 200
Study 26776270 — intervention group
Group type: EXPERIMENTAL
Intervention: Local RUTF
Number of subjects: 200
Study 26776270 — intervention group
Group type: COMPARATOR
Intervention: Standard RUTF (peanut-based with powdered milk)
Number of subjects: 200
Study 25947578 — intervention group
Group type: EXPERIMENTAL
Intervention: txt4two intervention (mHealth intervention promoting healthy nutrition, physical activity, and GWG)
Number of subjects: 100
Study 22524182 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation (FES)
Number of subjects: 16
Study 22524182 — intervention group
Group type: COMPARATOR
Intervention: Ankle foot orthosis (Control)
Number of subjects: 16
Study 21222186 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat stress (HS) applied to the belly of the vastus lateralis during resistance exercise
Number of subjects: 8
Study 19255015 — intervention group
Group type: EXPERIMENTAL
Intervention: Resuscitation with room air or 100% oxygen using pulse oximetry
Number of subjects: 24
Study 19255015 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of colorimetric carbon dioxide detectors during bag-and-mask ventilation
Number of subjects: 24
Study 19255015 — intervention group
Group type: EXPERIMENTAL
Intervention: Target peak inspiratory pressure of 30 cm H(2)O
Number of subjects: 24
Study 16545706 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine with 1:200,000 epinephrine
Number of subjects: 30
Study 16545706 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% levobupivacaine with 1:200,000 epinephrine
Number of subjects: 30
Study 16545706 — intervention group
Group type: EXPERIMENTAL
Intervention: Both solutions
Number of subjects: 30
Study 16545706 — intervention group
Group type: COMPARATOR
Intervention: 0.5% bupivacaine with 1:200,000 epinephrine and 0.5% levobupivacaine with 1:200,000 epinephrine
Number of subjects: 30
Study 12736013 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 microM N/OFQ
Number of subjects: 14
Study 12736013 — intervention group
Group type: COMPARATOR
Intervention: 1 microM [desPhe(1)]N/OFQ (placebo)
Number of subjects: 14
Study 10789612 — intervention group
Group type: EXPERIMENTAL
Intervention: Niaspan (extended-release niacin) at doses of 1500 and 2000 mg
Number of subjects: 173
Study 10789612 — intervention group
Group type: COMPARATOR
Intervention: Gemfibrozil 600 mg given twice daily
Number of subjects: 173
Study 9757699 — intervention group
Group type: EXPERIMENTAL
Intervention: Clemastin
Number of subjects: 200
Study 9757699 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenazolinum
Number of subjects: 200
Study 9757699 — intervention group
Group type: EXPERIMENTAL
Intervention: Zyrtec
Number of subjects: 200
Study 9757699 — intervention group
Group type: EXPERIMENTAL
Intervention: Astemizol
Number of subjects: 200
Study 9757699 — intervention group
Group type: EXPERIMENTAL
Intervention: Claritin
Number of subjects: 200
Study 9757699 — intervention group
Group type: EXPERIMENTAL
Intervention: Disophrol
Number of subjects: 200
Study 9757699 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 8161442 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-1 immunogen
Number of subjects: 15
Study 8161442 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 3518407 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisapride 10 mg, tid orally for 1 week
Number of subjects: 20
Study 3518407 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 31996042 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal septal reconstruction (ESR)
Number of subjects: 46
Study 31996042 — intervention group
Group type: COMPARATOR
Intervention: Endonasal septoplasty (ES)
Number of subjects: 46
Study 31996042 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 46
Study 29624694 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroplasticity-oriented targeted cognitive training for 4 weeks
Number of subjects: 61
Study 29624694 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 61
Study 29624694 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroplasticity-oriented targeted cognitive training
Number of subjects: 61
Study 26857887 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized resistance training performed three times a week for 15 weeks under supervision of a physiotherapist
Number of subjects: 60
Study 26857887 — intervention group
Group type: COMPARATOR
Intervention: Unchanged physical activity (control group)
Number of subjects: 60
Study 24294838 — intervention group
Group type: COMPARATOR
Intervention: Contingency Management (CM)
Number of subjects: 337
Study 24294838 — intervention group
Group type: COMPARATOR
Intervention: Assertive Continuing Care (ACC)
Number of subjects: 337
Study 24294838 — intervention group
Group type: COMPARATOR
Intervention: Combination of CM + ACC
Number of subjects: 337
Study 22430025 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided injection (4 mL of 0.5% bupivacaine and 40 mg methylprednisone)
Number of subjects: 23
Study 22430025 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopic-guided injection (4 mL of 0.5% bupivacaine and 40 mg methylprednisone)
Number of subjects: 23
Study 22430025 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided injection
Number of subjects: 23
Study 22430025 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopic-guided injection
Number of subjects: 23
Study 22430025 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided injection and Fluoroscopic-guided injection
Number of subjects: 23
Study 20831536 — intervention group
Group type: EXPERIMENTAL
Intervention: Gliclazide 80 mg
Number of subjects: 18
Study 18050054 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (EG)
Number of subjects: 30
Study 18050054 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 30
Study 16645536 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical micellar nanoparticle estradiol emulsion (MNPEE; 3.45 g daily dose containing 8.6 mg estradiol)
Number of subjects: 200
Study 16645536 — intervention group
Group type: COMPARATOR
Intervention: Placebo emulsion
Number of subjects: 200
Study 12417166 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet used without exsanguination
Number of subjects: 11
Study 12417166 — intervention group
Group type: COMPARATOR
Intervention: No tourniquet used (control)
Number of subjects: 11
Study 10628631 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ranitidine
Number of subjects: 1077
Study 10628631 — intervention group
Group type: COMPARATOR
Intervention: Nasogastric sucralfate
Number of subjects: 1077
Study 10628631 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrition
Number of subjects: 1077
Study 10628631 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum serum creatinine
Number of subjects: 1077
Study 8529985 — intervention group
Group type: EXPERIMENTAL
Intervention: DMSO gel 25%
Number of subjects: 112
Study 8529985 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel base
Number of subjects: 112
Study 2036999 — intervention group
Group type: EXPERIMENTAL
Intervention: salm-calcitonin
Number of subjects: 0
Study 7020816 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine (in doses recommended for use in general practice)
Number of subjects: 0
Study 7020816 — intervention group
Group type: COMPARATOR
Intervention: Psychotherapeutic help (usual range)
Number of subjects: 0
Study 30686575 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-step suture technique
Number of subjects: 240
Study 30686575 — intervention group
Group type: COMPARATOR
Intervention: Conventional sutures
Number of subjects: 240
Study 29179137 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Metacognitive Therapy (MCT) for 8 weeks
Number of subjects: 40
Study 29179137 — intervention group
Group type: COMPARATOR
Intervention: Mindfulness Based Stress Reduction (MBSR) for 8 weeks
Number of subjects: 40
Study 26899859 — intervention group
Group type: EXPERIMENTAL
Intervention: Talon cusps observed in patients
Number of subjects: 4116
Study 26899859 — intervention group
Group type: EXPERIMENTAL
Intervention: Type I talon cusp
Number of subjects: 4116
Study 26899859 — intervention group
Group type: EXPERIMENTAL
Intervention: Type II talon cusp
Number of subjects: 4116
Study 26899859 — intervention group
Group type: EXPERIMENTAL
Intervention: Type III talon cusp
Number of subjects: 4116
Study 24717149 — intervention group
Group type: EXPERIMENTAL
Intervention: 635 nm per 6 mW laser-emitting toothbrush
Number of subjects: 96
Study 24717149 — intervention group
Group type: COMPARATOR
Intervention: 635 nm per 12.9 μW light-emitting diode (LED) toothbrush
Number of subjects: 96
Study 22305012 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol A (525 mgI/kg)
Number of subjects: 128
Study 22305012 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol B (630 mgI/kg)
Number of subjects: 128
Study 20852182 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition (PN) for 3-15 days (T1)
Number of subjects: 46
Study 20852182 — intervention group
Group type: COMPARATOR
Intervention: Parenteral nutrition (PN) scheduled (T0)
Number of subjects: 46
Study 17413908 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 10
Study 17413908 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 10
Study 17413908 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 15632336 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacy access to EC
Number of subjects: 2117
Study 15632336 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance provision of 3 packs of levonorgestrel EC
Number of subjects: 2117
Study 15632336 — intervention group
Group type: COMPARATOR
Intervention: Control group (clinic access)
Number of subjects: 2117
Study 12384802 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E greater than 13 mg/day
Number of subjects: 99
Study 12384802 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C greater than 100 mg/day
Number of subjects: 99
Study 12384802 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene, vitamin C, vitamin E, and folic acid intake
Number of subjects: 99
Study 9771181 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (up to 2.5 mg.kg‐1)
Number of subjects: 71
Study 9771181 — intervention group
Group type: COMPARATOR
Intervention: Etomidate (0.3 mg.kg‐1)
Number of subjects: 71
Study 7800967 — intervention group
Group type: EXPERIMENTAL
Intervention: OM-85 BV
Number of subjects: 0
Study 7800967 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2894165 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilmenidine
Number of subjects: 333
Study 2894165 — intervention group
Group type: COMPARATOR
Intervention: Clonidine
Number of subjects: 333
Study 30352568 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised group training
Number of subjects: 200
Study 30352568 — intervention group
Group type: COMPARATOR
Intervention: Home-based training supported by smartphones, health coaches, and Fitbit technology
Number of subjects: 200
Study 30352568 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 200
Study 30352568 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost information
Number of subjects: 200
Study 26936608 — intervention group
Group type: COMPARATOR
Intervention: Capped chemotherapy in obese patients
Number of subjects: 325
Study 26936608 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncapped chemotherapy in obese patients
Number of subjects: 325
Study 26936608 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncapped chemotherapy in overweight or normal bodyweight patients
Number of subjects: 325
Study 24010867 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrective Babbling therapy
Number of subjects: 13
Study 24010867 — intervention group
Group type: COMPARATOR
Intervention: Immediate treatment (IT)
Number of subjects: 13
Study 24010867 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment (DT)
Number of subjects: 13
Study 22549573 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of a diary to family members of patients in intensive care
Number of subjects: 36
Study 22549573 — intervention group
Group type: COMPARATOR
Intervention: Control group (family members who did not receive a diary)
Number of subjects: 36
Study 19957195 — intervention group
Group type: EXPERIMENTAL
Intervention: PPI and rebamipide therapy
Number of subjects: 62
Study 19957195 — intervention group
Group type: COMPARATOR
Intervention: PPI alone
Number of subjects: 62
Study 18689564 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil (25 mL/day)
Number of subjects: 200
Study 15912074 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide infusion
Number of subjects: 30
Study 15355136 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical features predicted by prior knowledge
Number of subjects: 0
Study 15355136 — intervention group
Group type: EXPERIMENTAL
Intervention: Incongruent features predicted using knowledge from other domains
Number of subjects: 0
Study 15355136 — intervention group
Group type: EXPERIMENTAL
Intervention: Contradictory features violating prior knowledge
Number of subjects: 0
Study 10653329 — intervention group
Group type: EXPERIMENTAL
Intervention: LC-PUFA enriched formula
Number of subjects: 37
Study 10653329 — intervention group
Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 37
Study 10653329 — intervention group
Group type: COMPARATOR
Intervention: Human milk
Number of subjects: 37
Study 9294270 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 group (insufflation)
Number of subjects: 17
Study 9294270 — intervention group
Group type: COMPARATOR
Intervention: Air group (abdominal wall-lifting)
Number of subjects: 17
Study 9294270 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 17
Study 8279245 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol anaesthesia
Number of subjects: 60
Study 8279245 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane anaesthesia
Number of subjects: 60
Study 8279245 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol/nitrous oxide anaesthesia
Number of subjects: 60
Study 3490396 — intervention group
Group type: EXPERIMENTAL
Intervention: Gunsight (GU)
Number of subjects: 13
Study 3490396 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagined gunsight (IGU)
Number of subjects: 13
Study 3490396 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental arithmetic (MA)
Number of subjects: 13
Study 3490396 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual tracking (VT)
Number of subjects: 13
Study 3490396 — intervention group
Group type: EXPERIMENTAL
Intervention: Gunsight (GU) for vestibular patients
Number of subjects: 13
Study 3490396 — intervention group
Group type: COMPARATOR
Intervention: Imagined gunsight (IGU) for vestibular patients
Number of subjects: 13
Study 3490396 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual tracking (VT) for vestibular patients
Number of subjects: 13
Study 2484393 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidative cocktail (300 micrograms selenium as L‐selenomethionine, 45 mg zinc, 270 mg vitamin C, 2.7 mg vitamin A, 6 mg vitamin B‐6, 465 mg vitamin E, and 250 mg gamma‐linolenic acid daily for one year)
Number of subjects: 97
Study 2484393 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidative cocktail
Number of subjects: 97
Study 2484393 — intervention group
Group type: COMPARATOR
Intervention: Placebo (similar looking pills and capsules without active components)
Number of subjects: 97
Study 29986616 — intervention group
Group type: EXPERIMENTAL
Intervention: Persian version of the Identification of Functional Ankle Instability (IdFAI) questionnaire
Number of subjects: 120